Tom H M Ottenhoff
23PUBLICATIONS
97CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (23)
Sort by Publication Date:
|Jan 21, 2026
Antibodies in tuberculosis: functional capacity as key determinant.Krista E van Meijgaarden, Patricia S Grace, Natalia T Freund
|Jan 21, 2026
mTORC1 inhibitors rapamycin and everolimus as host-directed therapy for tuberculosis.Robin H G A van den Biggelaar, Tom H M Ottenhoff
|Mar 14, 2025
HLA-E/peptide complexes differentially interact with NKG2A/CD94 and T cell receptors.Linda Voogd, Remco L van den Broek, Marjolein van Wolfswinkel
|Jul 26, 2024
Identification of kinase inhibitors as potential host-directed therapies for intracellular bacteria.Robin H G A van den Biggelaar, Kimberley V Walburg, Susan J F van den Eeden
|Jun 25, 2024
Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy.Gül Kilinç, Ralf Boland, Matthias T Heemskerk
|Jun 19, 2024
Discovery of isoquinoline sulfonamides as allosteric gyrase inhibitors with activity against fluoroquinolone-resistant bacteria.Alexander T Bakker, Ioli Kotsogianni, Mariana Avalos
Pageof 4
Frequent Collaborators
7 joint publications
Simone A Joosten
4 joint publications
Krista E van Meijgaarden
4 joint publications
Marielle C Haks
3 joint publications
Paula Ruibal
2 joint publications
Delia Goletti
2 joint publications
Herman P Spaink
2 joint publications
Gerhard Walzl
2 joint publications
Matthias T Heemskerk
2 joint publications
Ralf Boland
2 joint publications
Marjolein van Wolfswinkel
